Chong Kun Dang Pharmaceutical Corp.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1941-01-01
- Employees
- 2.3K
- Market Cap
- -
- Website
- http://www.ckdpharm.com
Drug-drug Interaction Study(CKD-501, Amlodipine)
Phase 1
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2011-04-25
- Last Posted Date
- 2011-08-15
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 25
- Registration Number
- NCT01341392
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
CKD-828 (40/5mg) Pharmacokinetic Study
- First Posted Date
- 2011-04-22
- Last Posted Date
- 2011-04-28
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 68
- Registration Number
- NCT01340131
- Locations
- 🇰🇷
Inje University Pusan Paik Hospital, Pusan, Korea, Republic of
A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers
- First Posted Date
- 2011-04-22
- Last Posted Date
- 2011-12-22
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 24
- Registration Number
- NCT01340248
- Locations
- 🇰🇷
Kyungpook national university, Daegu, Seoul, Korea, Republic of
Drug-drug Interaction Study (CKD-501, Ketoconazole)
- First Posted Date
- 2011-04-07
- Last Posted Date
- 2011-06-29
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 24
- Registration Number
- NCT01330563
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects
Phase 1
Completed
- Conditions
- Chronic Myeloid LeukemiaGastrointestinal Stromal Tumors
- Interventions
- Drug: Luckyvec 400mg film coated tablet
- First Posted Date
- 2011-01-06
- Last Posted Date
- 2012-10-31
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 30
- Registration Number
- NCT01270984
- Locations
- 🇰🇷
The Korea University Anam Hospital, Seoul, Korea, Republic of
CKD-828(80/2.5mg) Pharmacokinetic Study
- First Posted Date
- 2010-11-23
- Last Posted Date
- 2011-01-19
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 65
- Registration Number
- NCT01246193
- Locations
- 🇰🇷
Inje Unuversity Pusan Paik Hospital, Pusan, Korea, Republic of
The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea
Phase 1
Completed
- Conditions
- Healthy Male Volunteer
- Interventions
- Drug: CKD-501 0.5 mg tablet, Glimepiride 4 mg tabletDrug: CKD-501 placebo tablet, Glimepiride 4 mg tablet
- First Posted Date
- 2010-05-28
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 24
- Registration Number
- NCT01133431
- Locations
- 🇰🇷
The Korea University Anam Hospital, Seoul, Korea, Republic of
CKD-828 Primary Hypertension Trial(Dose-selection)
Phase 2
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2010-05-21
- Last Posted Date
- 2011-04-26
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 430
- Registration Number
- NCT01128322
- Locations
- 🇰🇷
Hallym University Sacred Heart Hospital, Anyang, Korea, Republic of
🇰🇷Soonchunhyang University Hospital in Bucheon, Bucheon, Korea, Republic of
🇰🇷Kosin University Gospel Hospital, Busan, Korea, Republic of
Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin
Phase 3
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Drug: CKD-501 0.5mg
- First Posted Date
- 2010-04-19
- Last Posted Date
- 2013-02-15
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 253
- Registration Number
- NCT01106131
- Locations
- 🇰🇷
Kangbuk Samsung Hospital, Seoul, Korea, Republic of
The Effect of Food on the Pharmacokinetic Characteristics of CKD-501
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: CKD-501 1mg
- First Posted Date
- 2010-02-19
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 24
- Registration Number
- NCT01071720